HomeAbout

TL;DR CNBC


Biden administration examining role of supply chain middlemen in generic drug shortages - TL;DR CNBC

Biden administration examining role of supply chain middlemen in generic drug shortages

Publishing timestamp: 2024-02-14 12:54:16


Summary

The Federal Trade Commission is investigating the role of drug wholesalers and companies that purchase medicines for U.S. health-care providers in the shortages of generic drugs. The move follows a significant shortfall of crucial medicine over the last year, forcing hospitals to ration drugs. The FTC and Department of Health and Human Services are seeking public comment on contracting practices, market concentration, and compensation of middlemen in the drug supply chain.


Sentiment: NEGATIVE

Tickers: MCKCAHABC

Keywords: mckesson corpbusiness newsbusinessamerisourcebergen corpbiotech and pharmaceuticalspharmaceuticalsbiotechnologyhealth care industrysocial issuescardinal health incproducts and services

Source: https://www.cnbc.com/2024/02/14/ftc-hhs-examining-cause-of-generic-drug-shortages.html


Developed by Leo Phan